Utilizing Synergistic Potential of Mitochondria-Targeting Drugs for Leukemia Therapy

Acute myeloid leukemia (AML) is an aggressive group of cancers with high mortality rates and significant relapse risks. Current treatments are insufficient, and new therapies are needed. Recent discoveries suggest that AML may be particularly sensitive to chemotherapeutics that target mitochondria....

Descripción completa

Detalles Bibliográficos
Autores principales: Panina, Svetlana B., Pei, Jingqi, Baran, Natalia, Konopleva, Marina, Kirienko, Natalia V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146088/
https://www.ncbi.nlm.nih.gov/pubmed/32318340
http://dx.doi.org/10.3389/fonc.2020.00435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146088/
https://www.ncbi.nlm.nih.gov/pubmed/32318340
http://dx.doi.org/10.3389/fonc.2020.00435

Ejemplares similares